WEIS MARKETS INC — Form 8-K
Filed August 4, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 38/100
What the filing says
Weis Markets reported Q2 2026 total revenue of $1.28B (up 4.6% from $1.22B in Q2 2025) with comparable store sales up 2.3%, but net income fell 9.6% to $22.86M from $25.28M. Year-to-date revenue reached $2.53B (up 4.6%), though Q2 profitability declined due to approximately $10.71M in pharmacy headwinds from Inflation Reduction Act Medicare pricing provisions. EPS was $0.92 vs. $0.96 prior year; the board declared a $0.34/share quarterly dividend on 24.7M weighted-average shares outstanding.
Why this rating
Revenue growth modest but Q2 profit down sharply; pharmacy pricing pressure material (~$10.7M headwind is 1.6% of Q2 revenue). Relative to $682M market cap, YTD net income of $50.7M is ~7.4% of equity value. No structural change, routine quarterly disclosure.
See more from August 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.